165 related articles for article (PubMed ID: 35506763)
1. Crystal structure of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (hROR1).
Guarino SR; Di Bello A; Palamini M; Capillo MC; Forneris F
Acta Crystallogr F Struct Biol Commun; 2022 May; 78(Pt 5):185-192. PubMed ID: 35506763
[TBL] [Abstract][Full Text] [Related]
2. Solution structure, dynamics and function investigation of Kringle domain of human receptor tyrosine kinase-like orphan receptor 1.
Ma X; Liu B; Yang J; Hu K
J Biomol Struct Dyn; 2020 May; 38(8):2229-2239. PubMed ID: 31232192
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans.
Yoda A; Oishi I; Minami Y
J Recept Signal Transduct Res; 2003 Feb; 23(1):1-15. PubMed ID: 12680586
[TBL] [Abstract][Full Text] [Related]
4. Backbone and side-chain chemical shift assignments of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1).
Ma X; Zhang Y; Liu B; Yang J; Hu K
Biomol NMR Assign; 2018 Apr; 12(1):145-148. PubMed ID: 29313214
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique.
Aghebati-Maleki L; Younesi V; Jadidi-Niaragh F; Baradaran B; Majidi J; Yousefi M
Hum Antibodies; 2017; 25(1-2):57-63. PubMed ID: 28128766
[TBL] [Abstract][Full Text] [Related]
6. Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domains.
Bainbridge TW; DeAlmeida VI; Izrael-Tomasevic A; Chalouni C; Pan B; Goldsmith J; Schoen AP; Quiñones GA; Kelly R; Lill JR; Sandoval W; Costa M; Polakis P; Arnott D; Rubinfeld B; Ernst JA
PLoS One; 2014; 9(7):e102695. PubMed ID: 25029443
[TBL] [Abstract][Full Text] [Related]
7. Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications.
Goydel RS; Weber J; Peng H; Qi J; Soden J; Freeth J; Park H; Rader C
J Biol Chem; 2020 May; 295(18):5995-6006. PubMed ID: 32193207
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of Receptor Tyrosine Kinase-Like Orphan Receptors in Intestinal-Type Gastric Cancer.
Nema R; Patel P; Kumar A
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2125-2134. PubMed ID: 34319035
[TBL] [Abstract][Full Text] [Related]
9. Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.
Shabani M; Naseri J; Shokri F
Expert Opin Ther Targets; 2015 Jul; 19(7):941-55. PubMed ID: 25835638
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.
Daneshmanesh AH; Hojjat-Farsangi M; Khan AS; Jeddi-Tehrani M; Akhondi MM; Bayat AA; Ghods R; Mahmoudi AR; Hadavi R; Österborg A; Shokri F; Rabbani H; Mellstedt H
Leukemia; 2012 Jun; 26(6):1348-55. PubMed ID: 22289919
[TBL] [Abstract][Full Text] [Related]
11. ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy.
Rebagay G; Yan S; Liu C; Cheung NK
Front Oncol; 2012; 2():34. PubMed ID: 22655270
[TBL] [Abstract][Full Text] [Related]
12. ROR1, an embryonic protein with an emerging role in cancer biology.
Borcherding N; Kusner D; Liu GH; Zhang W
Protein Cell; 2014 Jul; 5(7):496-502. PubMed ID: 24752542
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules.
Hojjat-Farsangi M; Moshfegh A; Schultz J; Norin M; Olin T; Österborg A; Mellstedt H
Handb Exp Pharmacol; 2021; 269():75-99. PubMed ID: 34490515
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
[TBL] [Abstract][Full Text] [Related]
15. The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.
Hojjat-Farsangi M; Moshfegh A; Daneshmanesh AH; Khan AS; Mikaelsson E; Osterborg A; Mellstedt H
Semin Cancer Biol; 2014 Dec; 29():21-31. PubMed ID: 25068995
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of the extracellular region of human receptor tyrosine kinase like orphan receptor 2 (ROR2).
Li Y; Han X; Xu W; Rao Z; Li X
Protein Expr Purif; 2019 Jun; 158():74-80. PubMed ID: 30826310
[TBL] [Abstract][Full Text] [Related]
17. Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development.
Matsuda T; Nomi M; Ikeya M; Kani S; Oishi I; Terashima T; Takada S; Minami Y
Mech Dev; 2001 Jul; 105(1-2):153-6. PubMed ID: 11429290
[TBL] [Abstract][Full Text] [Related]
18. Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1.
Qi J; Li X; Peng H; Cook EM; Dadashian EL; Wiestner A; Park H; Rader C
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5467-E5476. PubMed ID: 29844189
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies.
Yang J; Baskar S; Kwong KY; Kennedy MG; Wiestner A; Rader C
PLoS One; 2011; 6(6):e21018. PubMed ID: 21698301
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells.
Hojjat-Farsangi M; Ghaemimanesh F; Daneshmanesh AH; Bayat AA; Mahmoudian J; Jeddi-Tehrani M; Rabbani H; Mellstedt H
PLoS One; 2013; 8(4):e61167. PubMed ID: 23593420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]